Evidence map›Paper›PMID 16108817›Full record

ArticleImmunology2005

Identification of specific autoantigens in Sjögren's syndrome by SEREX.

Kazuo Uchida, Yoichi Akita, Keitaro Matsuo, Shigeyoshi Fujiwara, Atsuko Nakagawa, Yoshiaki Kazaoka, Hiroshi Hachiya, Yoshiyuki Naganawa, Ichiro Oh-Iwa, Kiyoshi Ohura and 5 more

Open access · greenAbstract read
In one paragraph

Article in Immunology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 71 citations in OpenAlex.

  1. Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis.Liver international : official journal of the International Association for the Study of the Liver · 2015
    Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 2 countries.

Kazuo UchidaSecond Department of Oral and Maxillofacial Surgery, Aichi Gakuin University School of Dentistry, Nagoya, Japan. noriuchi@dpc.aichi-gakuim.ac.jp
Yoichi Akita
Keitaro Matsuo
Shigeyoshi Fujiwara
Atsuko Nakagawa
Yoshiaki Kazaoka
Hiroshi Hachiya
Yoshiyuki Naganawa
Ichiro Oh-Iwa
Kiyoshi Ohura
Shinsuke Saga
Tatsushi Kawai
Yoshinari Matsumoto
Kazuo Shimozato
Ken-Ichi Kozaki
Aichi Gakuin University · JPJapanese Red Cross Nagoya Daiichi Hospital · JPOsaka Dental University · JPAichi Cancer Center · JPAichi Medical University · JPNational Medical Research Center of Dentistry and Maxillofacial Surgery · RUOgaki Municipal Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We carried out SEREX (serological analysis of antigens by recombinant cDNA expression cloning) using sera from patients with Sjögren's syndrome (SjS) and investigated the frequencies of autoantibodies against autoantigens identified by SEREX in the sera of healthy individuals (HI) and patients with SjS, rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). IFI16 and two kelch-like proteins, KLHL12 and KLHL7, were found to be novel autoantigens in SjS by SEREX. A markedly high frequency of anti-IFI16 autoantibodies was observed in the sera of SjS (SjS, 70%; RA, 13%; SLE, 33%; HI, 0%). Interestingly, all serum samples from SjS demonstrated immunoreactivity against one or both of IFI16 and SS-B/La. The presence of autoantibodies against KLHL12 and KLHL7 in the sera was significantly specific to SjS (23% and 17%, respectively), as they were not detected in RA, SLE or HI. Furthermore, we confirmed that transcripts of these autoantigens were expressed preferentially in the salivary glands and immuno-privileged testes. Our results suggest these autoantigens may be useful as serological markers for the clinical diagnosis of SjS and may play a crucial role as organ-specific autoantigens in the aetiopathogenesis of SjS. This study warranted clinical evaluations of autoantibodies against IFI16, KLHL12 and KLHL7 in combination with anti-SS-B/La autoantibodies.

Indexed as

AdolescentAdultAgedAged, 80 and overAutoantibodiesAutoantigensAutoimmune DiseasesBlotting, NorthernBlotting, WesternFemaleGene LibraryHumansMaleMicrofilament ProteinsMiddle AgedNerve Tissue ProteinsAutoantibodiesAutoantigensIFI16 protein, humanKLHL2 protein, humanKLHL7 protein, humanMicrofilament ProteinsNerve Tissue ProteinsNuclear ProteinsPhosphoproteins

Identifiers

PMID16108817
PMCPMC1802401
OpenAlexW2031451009

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.